Immunotherapy for hepatocellular carcinoma: From basic research to clinical use

doi:10.4254/wjh.v7.i7.980

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13887)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

887

WORD

425

HTML

7267

Figures (1-1)

190

Tables (1-3)

125

Sum=8894

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

812

Download

1464

Sum=2276

Publishing Process of This Article

Item

Count

Browse

1124

Download

1593

Sum=2717

May 8, 2015 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. May 8, 2015; 7(7): 980-992
Published online May 8, 2015. doi: 10.4254/wjh.v7.i7.980

Full Size Figure Download Figure

Figure 1 Principles of immunotherapy on hepatocellular carcinoma. NK: Natural killer; LAK: Lymphokine-activated killer; NKT: Natural killer T; CIK: Chemokine-induced killer; CAR-T: Chimeric antigen receptor-T; HBV: Hepatitis B virus; MDSC: Myeloid-derived suppressor cells; Treg: Regulatory T; IL-2: Interleukin 2; IFN: Interferon; TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation; HCC: Hepatocellular carcinoma.

Citation: Hong YP, Li ZD, Prasoon P, Zhang Q. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World J Hepatol 2015; 7(7): 980-992
URL: https://www.wjgnet.com/1948-5182/full/v7/i7/980.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i7.980